By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Any device intended by the manufacturer to be used, either alone or in combination, for a medical purpose qualifies as a medical device. This includes instruments, apparatuses, implements, machines, appliances, implants, reagents for in vitro use, software, materials, and other similar or related items.
Medical equipment is crucial for the safe and efficient diagnosis, treatment, and rehabilitation of illness and disease, according to the World Health Organisation.
Medical device connectivity enables doctors to instantly obtain the most recent data and reduces errors and omissions in patient diagnostic data. As a result, professionals may spend more time with patients at their bedsides, improving the standard of treatment.
The Malaysia Medical Devices Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
The Medical Device Innovation Centre (MDIC) was established today by Sirim Bhd, a pioneer in technology and high-quality solutions, to expand the local medical device industry’s research and development (R&D) capabilities.
The creation of MDIC will make it possible to collaborate with a number of clever partners, including medical device manufacturers, the ministry and other government organisations, global innovation hubs, and university research institutions.
Additionally, it will seek to improve access to the markets for medical devices and develop a network of collaborative businesses that oversee and promote novel technology.
In Malaysia, Smith+Nephew recently inaugurated a centre for sophisticated manufacturing. The plant will primarily service the orthopaedics division of the British medtech behemoth, which the company anticipates will experience rapid growth in the Asia-Pacific area. In the neighbourhood, it has developed into a centre for medical equipment.
The electronic medical device registration system for applicants has been updated by the Malaysian Medical Device Authority (MDA) with better features and performance. For Malaysian market registrants, the MeDC@st 2.0 system offers a number of new and improved capabilities, including:
New features under the Clinical Research Module for various notification kinds, including Adverse Event Reporting and Scheduled Progress Reports, are available. A new Change Notification Module with provisions for applications for single and multiple submission identification numbers. tools for automatically generating letters of notification and change for applicants to print, a fresh credit card payment choice, etc.
Insulet Corporation, a US-based manufacturer of medical equipment, has chosen Malaysia as the location for one of its manufacturing facilities to create the Omnipod insulin management system.
The business celebrated the inauguration of the new site in Gelang Patah, Johor, which would increase the capacity of its current manufacturing facilities in the US and China.
